Naratuximab (Anti-TSPAN26 / CD37)
Naratuximab (Anti-TSPAN26 / CD37) is a humanized monoclonal antibody targeting CD37 (TSPAN26). It can be used to synthesize an ADC compound, naratuximab emtansine which is used in treatment of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma (DLBCL). MW : 150 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2600 |
| Sku # | A2600-1mg |
| Pricing | 1mg, $539.00 |